Abstract:The development of human trophoblast stem cells (hTSC) and stem cell-derived trophoblast organoids has enabled investigation of placental physiology and disease and early maternal-fetal interactions during a stage of human pregnancy that previously had been severely restricted. A key shortcoming in existing trophoblast organoid methodologies is the non-physiologic position of the syncytiotrophoblast (STB) within the inner portion of the organoid, which neither recapitulates placental villous morphology in vivo nor allows for facile modeling of STB exposure to the endometrium or the contents of the intervillous space. Here we have successfully established properly-polarized human trophoblast stem cell (hTSC)-sourced organoids with STB forming on the surface of the organoid. These organoids can also be induced to give rise to the extravillous trophoblast (EVT) lineage with HLA-G + migratory cells that invade into an extracellular matrix-based hydrogel. Compared to previous hTSC organoid methods, organoids created by this method more closely mimic the architecture of the developing human placenta and provide a novel platform to study normal and abnormal human placental development and to model exposures to pharmaceuticals, pathogens and environmental insults. Motivation: Human placental organoids have been generated to mimic physiological cell-cell interactions. However, those published models derived from human trophoblast stem cells (hTSCs) or placental villi display a non-physiologic "inside-out" morphology. In vivo , the placental villi have an outer layer of syncytialized cells that are in direct contact with maternal blood, acting as a conduit for gas and nutrient exchange, and an inner layer of progenitor, single cytotrophoblast cells that fuse to create the syncytiotrophoblast layer. Existing "inside-out" models put the cytotrophoblast cells in contact with culture media and substrate, making physiologic interactions between syncytiotrophoblast and other cells/tissues and normal and pathogenic exposures coming from maternal blood difficult to model. The goal of this study was to develop an hTSC-derived 3-D human trophoblast organoid model that positions the syncytiotrophoblast layer on the outside of the multicellular organoid.

Capturing Human Trophoblast Development with Naïve Pluripotent Stem Cells In Vitro

Naive Human Embryonic Stem Cells Can Give Rise to Cells with a Trophoblast-like Transcriptome and Methylome

Highly efficient generation of self-renewing trophoblast from human pluripotent stem cells

Isolation of pure primary term human cytotrophoblasts and their differentiation into syncytiotrophoblast-like cells as an ex vivo model of the human placenta

Derivation of trophoblast stem cells from naïve human pluripotent stem cells

Development of properly-polarized trophoblast stem cell-derived organoids to model early human pregnancy

Derivation of human trophoblast stem cells from placentas at birth

Establishment of Trophoblast‐Like Tissue Model from Human Pluripotent Stem Cells in Three‐Dimensional Culture System

Generation of Human Trophoblast Stem Cell-Dependent Placental in Vitro Models.

Directed Differentiation of Human Pluripotent Stem Cells to Cytotrophoblast and Syncytiotrophoblast

Trophoblast Organoids: Capturing the Complexity of Early Placental Development In Vitro

New era of trophoblast research: integrating morphological and molecular approaches

Long-term culture and passaging of term trophoblast for the investigation of syncytiotrophoblast function

Human archetypal pluripotent stem cells differentiate into trophoblast stem cells via endogenous BMP5/7 induction without transitioning through naive state

Frontier Progress in the Establishment of Trophoblast Stem Cell and the Identification of New Cell Subtypes at the Maternal-Fetal Interface

Transcription factor-based transdifferentiation of human embryonic to trophoblast stem cells

Conserved and divergent features of trophoblast stem cells

Trophoblast stem cell-based organoid models of the human placental barrier

Single-cell assessment of primary and stem cell-derived human trophoblast organoids as placenta-modeling platforms

Protocol to Derive Human Trophoblast Stem Cells Directly from Primed Pluripotent Stem Cells

Trophoblast Stem Cells1